Congruence Therapeutics
0 followers
‌
Congruence Therapeutics operates as a biotechnology company working at the interface of computational and experimental drug discovery to design novel small molecules for diseases of protein misfolding.
Industries
Headquarters
Employees
Links
Org chart
Katherine Bonter
Executive Director IP and Founder
Katherine Bonter
Collapse
Charles Grubsztajn
Chief Operating Officer
Michael-Rock Goldsmith, Ph.D.
Co-founder & Chief Innovation Scientist
Priya Karnick
Finance Manager
Sharath Hegde
Chief Scientific Officer
